Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* subject over 18 years of age~* having a neurogenic bladder with automatic catheter and pharmacologic disconnection of the detrusor muscle~* having at least 4 symptomatic UTIs per year with bacterial sensitivity to the chosen antibiotics~* having given full consent to participate in the study~* being the recipient of social security benefits~Exclusion Criteria:~* known allergy or hypersensitivity to useful antibiotics (to which the bacterium or bacteria are sensitive) or to one of their components~* other contraindication in the administering of useful antibiotics~* urinary volume flow \>500 ml during automatic catheter~* different urinary drainage method than automatic catheter~* occurrence of stones in the urinary tract~* infection due to endo urinary material (urinary prosthesis, ureteral stent)~* creatinine clearance \<60 ml/min~* patient under guardianship~* women who are pregnant, nursing, or who may become pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Weekly Oral Cyclic Antibiotic programme (Type: EXPERIMENTAL): None
- Classic care (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).